CD4 and neoplasm: Once activated by antigen-presenting cells (APCs), CD4+ T cells can rapidly differentiate into different subtypes: CD4+ effector T cell (Teff) exhibits anti-tumor activity, and regulatory T cell (Treg) has immunosuppressive and tumor-promoting effects (10).